Wnt5a promotes VM formation by modulating the stemness and EMT progression of prostate cancer cell
Open Access
- 1 November 2024
- journal article
- research article
- Published by Elsevier in Translational Oncology
- Vol. 51, 102155
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- WNT5A: a double-edged sword in colorectal cancer progressionMutation Research - Reviews in Mutation Research, 2023
- Newly identified form of phenotypic plasticity of cancer: immunogenic mimicryCancer and Metastasis Reviews, 2023
- Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancerCancer Cell, 2022
- HIF1α lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancerInternational Journal of Biological Macromolecules, 2022
- An emergent Wnt5a/YAP/TAZ regulatory circuit and its possible role in cancerSeminars in Cell & Developmental Biology, 2022
- Pre-existing Castration-resistant Prostate Cancer–like Cells in Primary Prostate Cancer Promote Resistance to Hormonal TherapyEuropean Urology, 2022
- Vasculogenic mimicry, a complex and devious process favoring tumorigenesis – Interest in making it a therapeutic targetPharmacology & Therapeutics, 2021
- Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinomaPharmacological Research, 2021
- Targeting vasculogenic mimicry by phytochemicals: A potential opportunity for cancer therapyIUBMB Life, 2020
- Inflammatory breast cancer: Activation of the aryl hydrocarbon receptor and its target CYP1B1 correlates closely with Wnt5a/b-β-catenin signalling, the stem cell phenotype and disease progressionJournal of Advanced Research, 2019